Skip to main content

Find Clinical Trials

Home
Conditions
Gastroparesis

Clinical trial condition

Gastroparesis

Explore clinical trials studying Gastroparesis. Study availability and eligibility vary by location and protocol.

133 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Gastroparesis trial results

Completed

A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040

NCT00562848

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Leuven, Belgium

View Trial Details

Completed

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

NCT00492622

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +12 more
Locations: Digestive Health Center, University of Louisville Hospital Louisville, Kentucky, United States

View Trial Details

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

NCT00733551

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Completed

Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes

NCT02324010

Conditions: Diabetes Mellitus, Digestive System Diseases, Endocrine System Diseases, +10 more
Locations: University of Adelaide, Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia

View Trial Details

Completed

FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers

NCT01294566

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

View Trial Details

Completed

GSK962040 Drug-drug Interaction Study With Ketoconazole

NCT01039974

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers

NCT01267071

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Nottingham, United Kingdom

View Trial Details

Completed

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

NCT00370084

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: University of Adelaide, Department of Medicine Adelaide, South Australia, Australia

View Trial Details

Completed

A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying

NCT01602549

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Randwick, New South Wales, Australia

GSK Investigational Site Ulm, Baden-Wurttemberg, Germany

GSK Investigational Site Bochum, North Rhine-Westphalia, Germany

GSK Investigational Site Bonn, North Rhine-Westphalia, Germany

View Trial Details

Completed

Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance

NCT01039805

Conditions: Digestive System Diseases, Gastrointestinal Diseases, Gastroparesis, +5 more
Locations: GSK Investigational Site Adelaide, South Australia, Australia

View Trial Details